Corporate Shareholder Information
Stock Transfer Agent and Registrar
The principal market for our common stock is the New York Stock Exchange. Our stock is also traded on various U.S. regional stock exchanges.
Stock Transfer Agent and Registrar
Computershare Investor Services
P.O. Box 505000
Louisville, KY 40233-5000
Telephone: 1-800-733-9393
Outside the U.S., Canada and Puerto Rico: 1-781-575-4591
Internet: www.computershare.com/investor
Shareholder Services and Programs
Please contact our Stock Transfer Agent and Registrar, Computershare, with inquiries concerning shareholder accounts of record and stock transfer matters, and for information on:
- Computershare Investment Program
- Direct purchase of Pfizer stock
- Dividend reinvestment
- Automatic monthly or bimonthly investments
- Book-entry share ownership
- Direct deposit of dividends
Pfizer Political Action Committee and Political Contributions
To review our most recent political action committee and corporate political contributions reports, visit www.pfizer.com/pac.
Patient Assistance
Patients in the U.S. who need help getting access to their Pfizer medicines should contact Pfizer RxPathways®. Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. To learn more about Pfizer RxPathways, visit www.PfizerRxPathways.com or call 1-844-989-PATH (7284).
Pfizer RxPathways is a joint program of Pfizer Inc. and the Pfizer Patient Assistance Foundation™.
Additional Information
You can find more information about Pfizer online:
- Website: www.pfizer.com
- Twitter: www.twitter.com/Pfizer
- Facebook: www.facebook.com/Pfizer
- LinkedIn: www.linkedin.com/company/pfizer
Unless otherwise noted herein, the trademarks, logos and service marks appearing in the Annual Review, whether appearing with the trademark symbol, are owned or licensed by Pfizer Inc. or its affiliates.
- Herceptin® is a registered trademark of Genentech, Inc.
- Remicade® is a registered trademark of Janssen Biotech, Inc.
- Bavencio® is a registered trademark of Merck KGaA.
- Xtandi® is a registered trademark of Astellas Pharma Inc.
- MabThera® is a registered trademark of F.Hoffman-Roche Ltd
- Rituxan® is a registered trademark of Biogen Idec Inc. and Genentech, Inc.
- Humira® is a registered trademark of AbbVie Biotechnology Ltd.
- Avastin® is a registered trademark of Genentech, Inc.
- Neulasta® is a registered trademark of Amgen Inc.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families